Member Info for GingetheWinge

Looks like the shorting crew are still selling in the hope they can trigger further falls. As it's largely based on the FUD falsehood of an imminent raise (please read the CEO's comments) we could see a very substantial and rapid recovery shortly. Pun intended.

No, I was being conservative.

£17.35 per share

Looks like the shortest target wasn’t met. Team FUD still spamming the usual drivel about raising cash. Next week should be interesting even if there isn’t any news.

The most annoying aspect of this recent short attack is the timing. This year's ISA is full and I don't have any spare cash. Otherwise it would all be going in here at this price.

My take is that there is something of great significance that can't yet be discussed but is surely imminent. Couple the eventual news with desperate shorters trying to close and I'm definitely missing out !

My read of this (apart from obvious sphericals about a placing from the dentist dodger) is similar. Something brewing that can’t be openly discussed for which there are only two real options. One it’s really just Ribena as Timster would say or two a deal of significance is being finalised.

As Alastair himself said, ‘don’t worry’.

Avacta and AS have been very clear in their communication to investors; it works so don't worry it's in hand just be patient.

Looks like there is another last ditch attempt at a short attack this morning. Ignore the FUDsters and check in later when they've gone. I think they are just about spent and hopefully we'll see a recovery this afternoon.

Its not, its rising. The shorters have had their fun.

But predictable given the past few mornings before updates. Buy into it and sell later today after the inevitable rise.

I wasn't expecting to be buying this morning but I couldn't resist. I'm going to be one of those pesky day traders today.

It's interesting to see that there is very little FUD on here at the moment. Normally at this stage of the cycle we are bombarded for a couple of days before news as the shorters give it their best shot.

I think it speaks volumes that the board is uniformly positive. Only two more sleeps....,.

They know you're looking so they are hiding. Until later....

Apologies for the many typos in that last post. Using my phone on the train and no edit functionality!

I suggest reading the companies RNS releases and data packages.

The patients would receive significantly more AVA600 than they would standard six. That’s is the whole point of what the company are doing.

Dox dosing is limited by side effects - principally lfe threatening cardiac toxicity. Whilst a great MoA against tumours, rarely curative as the maximum lifetime dose is reached before a ‘cure’

AVA6000 can be given in much higher doses, more frequently and for longer (maybe indefinitely) until the cancer has completely gone.

That is to say it may be a cure and the amount given will be greater. The amount charged per dose may also well be higher.

So in short. More profit, incredible PR for the company with ownership.

(I’m not even going to bother with the fact that this will be a proof of concept for Precision which can be applied to many more compounds)

Yes, this. 100%

The bull is off the scale today from FUDsters. Factually incorrect nonsense regarding Phase 3 and off-target FAP concentrated toxicity.

Complete ignorance of the accumulated data and RNS releases and most importantly the premise of using novel delivery of an EXISTING drug to IMPROVE toxicity profile and widen the therapeutic index.

AVA6000 will become the standard of care overnight.

Who was it said that ? Was it an investor ? Was it a ramper ? Was it some strange, unhygienic fellow who keeps changing their sobriquet ?

Or, was it a world renowned oncologist ? Oh yes that was it Dr William Tap.

He's on a roll at the mo'.

Seems Hurst was right again. Large volume and everyone looking to buy.

"It is Friday, next week will heavy volume and suddenly no sellers. "